Skip to main content
. 2007 Apr 5;56(10):1637–1644. doi: 10.1007/s00262-007-0310-7

Table 4.

Hematologic toxicity observed after administration of catumaxomab

Dose level I Dose level II Dose level III Dose level IV Dose level V
No. of patients N = 3 N = 1 N = 4 N = 5 N = 2
Anemia
 Grade 1/2/3/4 –/–/–/– –/–/–/– 1/–/–/– –/–/–/– 1/–/–/–
Leucocyte decrease
 Grade 1/2/3/4 –/–/–/– –/–/–/– –/–/–/– –/–/–/– –/1/–/–
Lymphocyte decrease
 Grade 1/2/3/4 –/–/–/– –/–/1/– –/–/–/– –/–/1/– –/–/1/–
Thrombocyte decrease
 Grade 1/2/3/4 –/–/–/– –/–/–/– –/–/–/– –/–/–/– 1/–/–/–